TOR1AIP1

Across TCGA pan-cancer cohorts, TOR1AIP1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TOR1AIP1 data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher TOR1AIP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TOR1AIP1 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

CESC, STAD, and SCLC are the cancer types where TOR1AIP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Median	All	0.156	0.798	<.001	36	view →
STAD	DFS	Median	II,III,IV	1.000	0.333	.021	26	view →
SCLC	OS	Median	All	0.082	0.708	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TOR1AIP1–CESC (OS)

Open the CESC breakdown →